Answers are grounded in this paper and cite their sources.
This collaborative review (between teams of chemists and chemical engineers) describes the current scientific and operational hurdles that prevent the utilisation of aerobic oxidation reactions for the production of speciality chemicals and active pharmaceutical ingredients (APIs).
No takes yet. Share an insight, caveat, or question.
Gavriilidis et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: